BIG News on Omicron | Stock Rotation NOW
FULL TRANSCRIPT
hey everyone me kevin here the rotation
to travel stocks might be happening
sooner than we suspect we're going to go
ahead and look at what's going on with
some of these travel stocks in just a
moment but first let's go ahead and get
through some of the updates that are
creating the catalyst that we're seeing
today so a first front-page news today
was about multiple new studies coming
out showing as expected that omicron is
mostly more mild and this is what we've
been expecting however the market has
been creating a little bit more fear
over omicron than is really justified
this is something that we've broken down
numerous times on the channel here that
there
the market was almost and has almost
been looking for a reason to be more
fearful than it really should be now
here are some notes from the latest
study so the latest study in scotland
these are a summary of the doctor the
one of the lead doctors on the study
and here's a summary of their notes of
what they thought about the study so
they mentioned although they studied a
small number the study is good news they
found that two-thirds or they found a
two-thirds reduction in hospitalization
of double vaccinated young people
compared to delta indicating that
omicron should be much more mild for
people they do say that there are a few
things to bear in mind the study is
rigorous but that it should be noted uh
that it'll take more time and more data
to really get the final results
they also mentioned that the study was
done early in the pandemic and focused
on younger people this is early in the
omicron
pandemic
and that the elderly of course are more
vulnerable they mentioned that although
a two-thirds reduction is significant
omicron can cause severe illness in the
doubly vaccinated and this was an
interesting line here that they
mentioned they say hey even though
more broadly it's substantially good it
is still possible to be severely ill
with a double vaccine it's obviously not
the best news for the vaccines but it's
also worth noting that we also got news
out of wall to read that we're expecting
positive results on that spfn
vaccine that 24 sided soccer ball style
protein that'll introduce 24 different
variants to you if you decide to take
that military military-grade vaccine
watch my video specifically on that if
you want to learn more about that but
that was also seen as a potentially
another positive catalyst for travel
stocks of course that we could have
positive results fully reported within
the next two weeks and we're expecting
those results to be positive it's just
going to be a matter of how positive
they are for that new potential vaccine
but regarding the study here regarding
pfizer and and the other mrna uh double
vaccinated vaccines it is still possible
to get severely ill with the vaccine
however you have a substantial reduction
very significant reduction they do
believe that omicron could continue to
double every few days and that they do
believe if it does that we could
generate more hospitalizations than
delta from a double vaccinated
population even so so they're really
proceeding here with cautious optimism
they mentioned that the best news from
their study is the observation that the
booster is highly effective at reducing
severe illness so if you want to reduce
that chance of severe illness
getting that booster highly important
remember that booster is really helping
you get to that
70 to 75 range in reducing the odds of
having a severe case of of omicron which
is huge pretty crudely they say we have
more time to get people boosted but we
can't waste a moment of it everything we
can do as individuals to slow the spread
gives us more time in my view there are
now solid reasons to favor a more
optimistic outcome of omicron in the
united kingdom then was feared and none
of this of course should diminish the
lives that have been lost so uh this is
important this is definitely a catalyst
for a lot of companies that we're seeing
right now uh especially for example the
cruise line stocks up
3.46 percent today we've actually really
started coming up
since about thursday so we had a green
day going into a friday we had about a
seven percent run between friday and
monday
and then we've run a total of about 20
percent now since last thursday so in in
six uh in six days we've run about
21
on the travel stocks it is worth noting
though that we're still lower than where
we have previously been if we zoom out
onto the day chart uh on uh carnival
cruise lines for example we do see some
pain here going into the delta variant
uh delta brought us down to somewhere
around 2147
which is approximately where we're
trading now right now we're trading at
about 20 83 and after hours so still a
little bit of a discount but we do see
we've clearly jumped back over that 20
line for carnival cruise lines and we're
seeing a lot of other recovery stocks
behave very similarly whether it's the
airlines or the cruise line so we're
starting to see this rotation this
study's news obviously very good this is
what we were expecting especially after
the uh the inflection point down in
cases in south africa now it's worth
noting that yeah even though we've seen
an inflection point down in cases in
south africa there are still concerns
that different parts of south africa
might be responding differently than
more highly vaccinated or more highly
exposed or previously exposed to covet
areas and this is important to pay
attention to because in the united
states it's estimated that somewhere
between 60 to 75 million individuals do
not have either prior exposure to covet
or a vaccine
so this is in contrast to the
expectation that over 90 plus percent of
the individuals in south africa have
either the vaccine or prior exposure to
covet potentially making
omicron less severe but that is exactly
why this study today out of scotland
with the oxford professors notes we just
saw is so bullish for for recovery
stocks and we're already seeing this
recovery get priced in mostly because
what we're seeing is hey look we are
potentially going to see an inflection
point regardless of whether we have had
prior exposure or not in our communities
because the united kingdom does not have
as much prior immunity like south africa
either now the united kingdom has been
great with vaccinations but still the
study bullish and this is the kind of
news that we've been seeing over the
last couple days not only the inflection
point to the downside in cases in south
africa and hospitalizations remaining
flat but the same kind of a thing now
happening in the united kingdom and
we're hoping that happens in the united
states as well so overall good news and
we're already starting to see stocks
respond positively to this this in my
opinion is a little bit sooner than
expected i was expecting to continue to
see a surge in omicron cases at the same
time as hospitalizations rotating up
because of lingering delta cases however
now we're nearly 80 percent dominant
with omicron cases in the united states
which means we're likely to slow the
amount of increased hospitalizations we
see in the united states
and even though prior waves have usually
lasted about five months so we've had
sort of five month waves of covid that
have spread through different states at
different times omicron might end up
being here and gone much faster than
previously believed we're expecting that
new york city according to dr scott
goblin today will peak around
mid-january in terms of cases and that
we might see other areas
peak shortly thereafter as well like
areas around
seattle
or various areas around the tri-state
area around new york city all of them
expected to potentially peak by
mid-january and if these are right now
are potentially the bulk of cases or
we're not even necessarily testing the
bulk of cases and catching them because
folks aren't getting tested because
they're mostly having relatively mild
symptoms then maybe we might actually be
vastly underreporting how much omicron
there really is right now remember as of
even two weeks ago in wastewater samples
in florida in orange county we were
realizing that wait a minute omicron is
already dominant here maybe but we're
not seeing that show up in testing yet
but somewhat implies that
much of our population may already be
getting exposed to omicron without this
coming up and testing so uh this is why
over the last three days we've kind of
started seeing a little bit of a u-turn
in a recovery stocks earlier than
expected the united kingdom's growth
rate for cases is also slowing according
to uh the the cuba tracker in the united
kingdom that updates at 3 pm london a
local time daily we're up from 80 000
cases last week to about 140 thousand
cases now that's still under reported on
some websites but if you look at the
zokov tracker
zoe cover tracker uh which might be
pronounced zoe in the united kingdom uh
we we've seen cases go to about 140 000
but the rate actually hasn't been that
strong we've been fearful about this
doubling rate of coven but four days ago
we were at 121 cases 121 000 cases in
the united kingdom right now we're at
140 000 cases so either omicron is
spreading at a doubling rate and we're
just not tracking all of these or
omicron is actually spreading slower
than expected which is also
reiterating that good news for recovery
stocks
now according to a study by oregon
health and a science university
breakthrough covet cases do tend to
generate a very enhanced immune response
the study found that antibodies from
blood samples of breakthrough cases
which were as much as 1 000 times more
effective than antibodies generated by
the pfizer vaccine two weeks after the
second dose so what this is really
telling us is that if you do end up
getting omicron your your body's
lingering response can actually be very
very strong after your infection to
potentially future variants so this is
very good news it's almost kind of like
hey if you get omicron and all of a
sudden you have a 1 000 percent increase
in in antibodies compared to a double
vaccine dose of pfizer it shows that
natural immunity is is potentially going
to give us the strength to power through
any potential new variants that come up
and if we get to herd immunity with
something like omicron then this turns
into that official nothing burger and uh
we we go back to normal uh and we take
away omicron as a as and potentially
even the pandemic as as a catalyst for
markets to be nervous and given that
there's a lot of fear around pandemics
creating supply chain delays leading to
inflation uh and potentially uh
pandemics leading to more fiscal
stimulus or even monetary stimulus
leading to more inflation fears as well
then if we take away the pandemic as a
catalyst we we could potentially finally
start seeing inflation rotate back down
to normal expected levels uh somewhere
between two and three percent by the end
of 2023 uh considering of course that
we're going to still see housing
inflation and wage inflation but overall
we could actually be on a good
trajectory for the market so i think
it's a reason to be optimistic
now health officials do say that as of
saturday we're at a 93 dominance we do
think that this is about 80 now as i've
already mentioned the world health
organization director general called for
the public to cancel upcoming events due
to omicron i honestly don't think most
people are taking that very seriously in
the united states with the exception of
a new york city where you are seeing a
lot of events getting cancelled on
tuesday joe biden mentioned that he's
going to take a look at another travel
ban to or or look take a look at his
existing travel bans to south africa and
seven other countries saying that the
travel ban was necessary when they
didn't have much information but now
we're past that and he's expecting to
potentially lift this travel ban he also
announced on tuesday the purchase of 500
500 million at home rapid covet 19 tests
and what they expect is
that this should serve about four tests
per household and they're going to
announce some form of a website where
we'll be able to order these honestly by
the time we actually get these i
wouldn't be surprised if it's somewhere
around mid-january and we kind of start
hopefully ushering in the end of the
pandemic unless of course we get some
other bizarre new variant or some other
garbage that i don't even want to think
about right now according to nbc also uh
dr fauci mentioned that the omicron
variant will almost certainly account
for 100 of cases within about the next
week to two so potentially by the end of
the year we could be all omicron which
at the moment is indicating uh that i
mean this this this is expected to be
very good news south africa's cases have
dropped uh uh from a high of 27 000
cases the numbers dropped to about 15
400
as of uh the last count now bloomberg is
also reporting that the drop in cases
may be to less maybe due to less testing
because uh on the day they reported a 44
a drop in cases 29 29.9 of a test
analyzed returned positive similar to
that 30.7
of positive tests uh the day before
then uh we also have the australian
prime minister mentioning that despite
large increases in new cases they have
not seen a significant impact on their
hospitals which is very very good this
is uh this is excellent they've been
incredibly strict of four lockdowns with
big consequences for breaching the rules
we saw a lot of police interventions uh
questionable behavior by police
especially against protesters like
instances of people walking their local
park or or out of uh or out on a walk
from work in the morning and then being
tackled or man there's been a lot of
drama in australia about this i don't
really want to take a political position
on this but there's been a lot of drama
on this
uh then on top of this we also had
excellent news that uh well first of all
the not so good news is we know that
merck's uh covet pill is not anywhere
near as effective in reducing the risk
of hospitalization and death as a
pfizer's pill mark's pill is only about
30 effective remember that red pill
we've talked about on the channel
however pfizer's covered 19 pill shows
that it's 90 effective the pill now has
fda approval which allows doctors to
prescribe the medicine to anyone 12 and
older who's considered high risk
the pill targets individuals who have
just gotten sick so should be taken as
soon as you notice symptoms the pill is
called paxlovit tens of thousands of
packs of pills are reported to be ready
to go in pfizer's warehouse the pill is
substantially effective as long as you
take the pill within three days of your
onset of symptoms with omicron surging
there are some concerns we might run out
of a supply of this
this drug though and that's
unfortunately because
the active ingredients within this pill
can take somewhere around six months to
actually manufacture and put together
and so there there is sometimes even up
to eight months so there is the
potential that we're not going to have
as many of these as potentially
necessary advisors looking to produce
3.6 billion of these tablets next year
you do have to take the pills uh they're
sort of like a pill box which contains
30 tablets over a five day period uh
they're making 3.6 billion tablets of
them so so we should have quite a few of
these available for for individuals
however it's going to take time by
january of 2022 they're trying to get to
50 million packs
which is nice but again honestly by the
time we actually get these distributed
hopefully omicron has uh uh become uh
has continued to prove to be mild
continue to uh prove to be uh something
that uh maybe even ushers in the end of
the pandemic and uh hopefully this all
comes to an end so there we go that is
the news on omicron i think it's uh
mostly
positive news and i appreciate you
watching this video if you found it
helpful consider sharing it check out my
programs on building your wealth down
below with that coupon code expiring at
the end of christmas day and folks we'll
see in the next one thanks so much
goodbye
UNLOCK MORE
Sign up free to access premium features
INTERACTIVE VIEWER
Watch the video with synced subtitles, adjustable overlay, and full playback control.
AI SUMMARY
Get an instant AI-generated summary of the video content, key points, and takeaways.
TRANSLATE
Translate the transcript to 100+ languages with one click. Download in any format.
MIND MAP
Visualize the transcript as an interactive mind map. Understand structure at a glance.
CHAT WITH TRANSCRIPT
Ask questions about the video content. Get answers powered by AI directly from the transcript.
GET MORE FROM YOUR TRANSCRIPTS
Sign up for free and unlock interactive viewer, AI summaries, translations, mind maps, and more. No credit card required.